| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2008, p. 2950-2954, Vol. 52, No. 8
0066-4804/08/$08.00+0 doi:10.1128/AAC.01672-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris Sud, Le Kremlin-Bicêtre, France,1 Department of Infectious Diseases and Clinical Microbiology,2 Department of Microbiology, Istanbul Faculty of Medicine, Capa, Istanbul, Turkey3
Received 27 December 2007/ Returned for modification 10 February 2008/ Accepted 24 May 2008
The first outbreak of carbapenem-resistant Klebsiella pneumoniae isolates producing the plasmid-encoded carbapenem-hydrolyzing oxacillinase OXA-48 is reported. The 39 isolates belonged to two different clones and were collected at the University Hospital of Istanbul, Turkey, from May 2006 to February 2007, and they coproduced various β-lactamases (SHV-12, OXA-9, and TEM-1 for clone A and CTX-M-15, TEM-1, and OXA-1 for clone B).
Published ahead of print on 2 June 2008.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |